Fundraising Fox

Michael Anstey

Investor

Partner at Cambridge Innovation Capital

Cambridge, United Kingdom

Writes $600K – $6M checks · typically $3.3M

About

Michael Anstey pairs a DPhil in Zoology with co-founding an early-stage biotech targeting protein–protein interactions, backed Bicycle Therapeutics and Nuclera, and co-founded Innovate Cambridge to boost Greater Cambridge's innovation ecosystem.

LinkedIn ↗

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductors

Experience

  1. Cambridge Innovation CapitalPartnercurrent2017 — presentCambridge, United Kingdom
  2. TRIMTECH Therapeutics LimitedBoard Membercurrent2024 — presentCambridge
  3. NucleraBoard Observercurrent2024 — presentCambridge, England, United Kingdom
  4. ImmutrinBoard Membercurrent2022 — presentCambridge, England, United Kingdom
  5. EpitopeaBoard Membercurrent2021 — presentCambridge, England, United Kingdom
  6. Innovate CambridgeBoard Membercurrent2022 — presentCambridge, England, United Kingdom
  7. Start CodonBoard Membercurrent2019 — presentCambridge, United Kingdom
  8. CongenicaBoard Member2018 — 2025Cambridge, United Kingdom
  9. STORM Therapeutics LimitedBoard Member2018 — 2023Cambridge, United Kingdom
  10. Bicycle TherapeuticsBoard Member2017 — 2020Cambridge, United Kingdom
  11. Proteorex Therapeutics Inc.Co-Founder2014 — 2018Toronto, Canada Area
  12. The Boston Consulting GroupPrincipal2010 — 2017Toronto, Canada
  13. Oxford Capital PartnersInvestment Analyst2008 — 2009Oxford, United Kingdom

Education

  1. Kauffman Fellow (Class 22)2017 — 2019
  2. University of OxfordDPhil, Department of Zoology2003 — 2007
  3. Queen's UniversityFirst Class BSc(Hons), Biology1999 — 2003
  4. Royal St George's College1990 — 1999

Skills & more

Leadership23Strategy10Team Leadership2Valuation3Venture Capital29Corporate Development4Due Diligence6Business Strategy30Investments9Healthcare2Research7Management Consulting15
+7 moreChange ManagementScienceStart-upsLifesciencesPrivate EquityFinancial ModelingProject Team Management

From Michael's professional profile.

Same school

Also attended University of Oxford688

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 682 more

Also attended Queen's University173

Hark AhluwaliaAssociate at RevolutionSydney SloanChief Marketing Officer at Scale Venture PartnersRares CrisanInvestor at GGV CapitalCURTIS URBANOWICZInvestment at Makers FundSanjiv KalevarPartner at Mucker CapitalAustin PringleAnalyst at Congruent Ventures

+ 167 more

Shared employers

Also worked at TRIMTECH Therapeutics Limited3

Damian Crowtherex-AstraZeneca at PICUS CAPITALJeffrey MoorePresident at MC Healthcare VenturesHakan GokerManaging Director at M Ventures

Also worked at Nuclera1

Jonathan MilnerInvestor at Cambridge Innovation Capital

Also worked at Immutrin3

Martin TaylorPrincipal at F-Prime Capital PartnersNihal SinhaPartner at F-Prime Capital PartnersMahesh KudariSenior Associate at SR One Capital Management

Also worked at STORM Therapeutics Limited5

Robert TansleyPartner at Cambridge Innovation CapitalChristine MartinHead of Ventures at University of Cambridge EnterpriseHakan GokerManaging Director at M VenturesSeiji MiyaharaSenior Investment Director at Taiho Ventures, LLCChristopher O'DonnellPartner at Pfizer Venture Investments

Colleagues at Cambridge Innovation Capital

Adam Glinsman
Investor at Cambridge Innovation Capital
Andrew Williamson
Managing Partner at Cambridge Innovation Capital
Andy Neely
Vice Chair at Cambridge Innovation Capital
Andy Richards
Investor at Cambridge Innovation Capital
Anne Horgan
Partner at Cambridge Innovation Capital
Christopher Tapper
Senior Associate at Cambridge Innovation Capital
Damian Crowther
Entrepreneur in Residence at Cambridge Innovation Capital
Dipesh Patel
Operating Partner at Cambridge Innovation Capital

Network4

Andrew Williamson
Managing Partner at Cambridge Innovation Capital
Anne Horgan
Partner at Cambridge Innovation Capital
Christopher Tapper
Senior Associate at Cambridge Innovation Capital
Edward Inns
Principal at Cambridge Innovation Capital

Investors connected to Michael in public investor directories — a warm-intro map.